Lexicon Historical Balance Sheet

LXRX Stock

USD 0.82 0.01 1.20%

Trend analysis of Lexicon Pharmaceuticals balance sheet accounts such as Total Current Liabilities of 48.4 M provides information on Lexicon Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Lexicon Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Lexicon Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Lexicon Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lexicon Pharmaceuticals is a good buy for the upcoming year.

Lexicon Pharmaceuticals Inventory

416,242

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.

About Lexicon Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lexicon Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Lexicon Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lexicon Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lexicon currently owns. An asset can also be divided into two categories, current and non-current.

Lexicon Pharmaceuticals Balance Sheet Chart

At this time, Lexicon Pharmaceuticals' Total Current Assets are fairly stable compared to the past year. Accumulated Other Comprehensive Income is likely to rise to about 37.4 K in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 76.2 M in 2025.

Total Assets Short Long Term Debt Total Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Lexicon Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lexicon Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Lexicon Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lexicon Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Lexicon Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lexicon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.At this time, Lexicon Pharmaceuticals' Total Current Assets are fairly stable compared to the past year. Accumulated Other Comprehensive Income is likely to rise to about 37.4 K in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 76.2 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	55.3M	106.1M	122.0M	76.2M
Total Assets	194.3M	229.4M	263.8M	326.8M

Short Long Term Debt Total Total Assets

Lexicon Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Assets
Total Assets		0.41	0.22	0.68	0.37	0.37	0.5	-0.57	-0.09	0.47	0.84	0.74	0.14	0.98	0.18	-0.09	0.87	0.71	0.45	0.08	0.78	0.31	0.98	0.34	0.52	-0.4
Short Long Term Debt Total	0.41		0.39	0.44	-0.18	-0.09	0.24	0.36	-0.36	0.54	0.15	0.19	-0.16	0.38	0.56	0.14	0.5	0.89	0.0	-0.33	0.82	-0.14	0.44	0.09	0.25	-0.18
Other Current Liab	0.22	0.39		0.54	-0.12	-0.37	0.61	0.21	-0.32	0.27	0.0	-0.23	-0.2	0.28	0.65	0.19	0.43	0.3	0.06	-0.14	0.42	-0.43	0.34	-0.06	0.14	-0.11
Total Current Liabilities	0.68	0.44	0.54		0.29	0.0	0.81	-0.38	-0.17	0.86	0.65	0.31	-0.11	0.74	0.17	-0.01	0.79	0.58	0.1	0.1	0.8	-0.07	0.73	0.29	0.24	-0.3
Total Stockholder Equity	0.37	-0.18	-0.12	0.29		0.17	0.13	-0.5	0.29	0.18	0.43	0.2	-0.22	0.43	-0.35	-0.06	0.35	-0.03	0.36	0.34	0.09	0.1	0.38	0.4	-0.11	-0.18
Property Plant And Equipment Net	0.37	-0.09	-0.37	0.0	0.17		-0.23	-0.41	0.42	0.02	0.37	0.78	-0.15	0.22	-0.02	-0.47	0.19	0.19	-0.23	-0.24	0.14	0.98	0.2	0.17	0.12	-0.5
Current Deferred Revenue	0.5	0.24	0.61	0.81	0.13	-0.23		-0.27	-0.44	0.59	0.43	0.03	0.12	0.62	0.09	0.34	0.65	0.36	0.01	0.37	0.56	-0.22	0.6	-0.09	0.35	0.12
Net Debt	-0.57	0.36	0.21	-0.38	-0.5	-0.41	-0.27		-0.35	-0.16	-0.86	-0.51	-0.25	-0.6	0.45	0.48	-0.35	-0.02	-0.4	-0.17	-0.15	-0.37	-0.53	-0.37	-0.14	0.46
Retained Earnings	-0.09	-0.36	-0.32	-0.17	0.29	0.42	-0.44	-0.35		-0.26	0.17	0.05	-0.11	-0.11	-0.05	-0.8	-0.17	-0.23	-0.08	-0.54	-0.23	0.35	-0.12	0.36	-0.76	-0.58
Accounts Payable	0.47	0.54	0.27	0.86	0.18	0.02	0.59	-0.16	-0.26		0.47	0.31	-0.24	0.49	0.04	0.07	0.65	0.56	-0.07	0.15	0.73	-0.02	0.47	0.24	0.25	-0.17
Cash	0.84	0.15	0.0	0.65	0.43	0.37	0.43	-0.86	0.17	0.47		0.65	0.16	0.85	-0.18	-0.42	0.65	0.5	0.44	0.01	0.61	0.3	0.81	0.42	0.29	-0.58
Non Current Assets Total	0.74	0.19	-0.23	0.31	0.2	0.78	0.03	-0.51	0.05	0.31	0.65		-0.05	0.6	-0.04	-0.22	0.51	0.51	0.18	0.01	0.5	0.74	0.58	0.22	0.53	-0.43
Non Currrent Assets Other	0.14	-0.16	-0.2	-0.11	-0.22	-0.15	0.12	-0.25	-0.11	-0.24	0.16	-0.05		0.2	-0.08	-0.01	-0.03	-0.11	0.2	0.17	-0.12	-0.04	0.19	0.19	0.2	0.18
Cash And Short Term Investments	0.98	0.38	0.28	0.74	0.43	0.22	0.62	-0.6	-0.11	0.49	0.85	0.6	0.2		0.13	-0.04	0.88	0.67	0.47	0.15	0.77	0.17	0.99	0.33	0.46	-0.33
Net Receivables	0.18	0.56	0.65	0.17	-0.35	-0.02	0.09	0.45	-0.05	0.04	-0.18	-0.04	-0.08	0.13		-0.06	0.29	0.41	-0.09	-0.54	0.36	-0.07	0.24	0.15	0.03	-0.24
Common Stock Shares Outstanding	-0.09	0.14	0.19	-0.01	-0.06	-0.47	0.34	0.48	-0.8	0.07	-0.42	-0.22	-0.01	-0.04	-0.06		0.08	0.0	-0.04	0.69	0.0	-0.37	-0.04	-0.51	0.43	0.87
Short Term Investments	0.87	0.5	0.43	0.79	0.35	0.19	0.65	-0.35	-0.17	0.65	0.65	0.51	-0.03	0.88	0.29	0.08		0.7	0.29	0.13	0.81	0.15	0.89	0.16	0.39	-0.23
Non Current Liabilities Total	0.71	0.89	0.3	0.58	-0.03	0.19	0.36	-0.02	-0.23	0.56	0.5	0.51	-0.11	0.67	0.41	0.0	0.7		0.1	-0.29	0.95	0.13	0.7	0.09	0.35	-0.35
Other Current Assets	0.45	0.0	0.06	0.1	0.36	-0.23	0.01	-0.4	-0.08	-0.07	0.44	0.18	0.2	0.47	-0.09	-0.04	0.29	0.1		0.24	0.11	-0.3	0.49	0.32	0.31	-0.17
Other Stockholder Equity	0.08	-0.33	-0.14	0.1	0.34	-0.24	0.37	-0.17	-0.54	0.15	0.01	0.01	0.17	0.15	-0.54	0.69	0.13	-0.29	0.24		-0.18	-0.15	0.09	-0.2	0.47	0.67
Total Liab	0.78	0.82	0.42	0.8	0.09	0.14	0.56	-0.15	-0.23	0.73	0.61	0.5	-0.12	0.77	0.36	0.0	0.81	0.95	0.11	-0.18		0.07	0.79	0.18	0.34	-0.37
Property Plant And Equipment Gross	0.31	-0.14	-0.43	-0.07	0.1	0.98	-0.22	-0.37	0.35	-0.02	0.3	0.74	-0.04	0.17	-0.07	-0.37	0.15	0.13	-0.3	-0.15	0.07		0.13	0.08	0.16	-0.36
Total Current Assets	0.98	0.44	0.34	0.73	0.38	0.2	0.6	-0.53	-0.12	0.47	0.81	0.58	0.19	0.99	0.24	-0.04	0.89	0.7	0.49	0.09	0.79	0.13		0.34	0.46	-0.35
Short Term Debt	0.34	0.09	-0.06	0.29	0.4	0.17	-0.09	-0.37	0.36	0.24	0.42	0.22	0.19	0.33	0.15	-0.51	0.16	0.09	0.32	-0.2	0.18	0.08	0.34		-0.06	-0.54
Common Stock	0.52	0.25	0.14	0.24	-0.11	0.12	0.35	-0.14	-0.76	0.25	0.29	0.53	0.2	0.46	0.03	0.43	0.39	0.35	0.31	0.47	0.34	0.16	0.46	-0.06		0.17
Other Assets	-0.4	-0.18	-0.11	-0.3	-0.18	-0.5	0.12	0.46	-0.58	-0.17	-0.58	-0.43	0.18	-0.33	-0.24	0.87	-0.23	-0.35	-0.17	0.67	-0.37	-0.36	-0.35	-0.54	0.17

Click cells to compare fundamentals

Lexicon Pharmaceuticals Account Relationship Matchups

Lexicon Pharmaceuticals balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	203.8M	136.9M	194.3M	229.4M	263.8M	326.8M
Short Long Term Debt Total	12.8M	2.3M	55.3M	106.1M	122.0M	76.2M
Other Current Liab	29.1M	11.9M	11.5M	15.9M	18.2M	12.8M
Total Current Liabilities	46.8M	22.1M	23.2M	31.5M	36.3M	48.4M
Total Stockholder Equity	156.4M	(1.5B)	(1.6B)	93.1M	83.8M	88.0M
Property Plant And Equipment Net	295K	1.2M	2.1M	7.5M	6.8M	6.4M
Net Debt	(113.5M)	(61.8M)	8.9M	83.6M	75.2M	79.0M
Retained Earnings	(1.4B)	(1.5B)	(1.6B)	(1.8B)	(1.6B)	(1.5B)
Accounts Payable	5.5M	9.2M	10.4M	14.4M	16.5M	13.3M
Cash	126.3M	64.1M	46.3M	22.5M	25.8M	24.5M
Non Current Assets Total	46.1M	48.0M	53.4M	52.9M	60.8M	104.9M
Non Currrent Assets Other	1.2M	2.3M	6.8M	828K	745.2K	707.9K
Cash And Short Term Investments	152.3M	86.7M	138.4M	170.0M	195.5M	206.8M
Net Receivables	395K	14K	28K	1.0M	1.2M	1.1M
Common Stock Shares Outstanding	110.8M	145.7M	165.7M	221.1M	254.3M	267.0M
Short Term Investments	26.0M	22.7M	92.0M	147.6M	169.7M	137.0M
Liabilities And Stockholders Equity	203.8M	(1.5B)	(1.5B)	229.4M	206.5M	216.8M
Non Current Liabilities Total	611K	1.2M	54.0M	104.8M	120.5M	100.6M
Other Current Assets	10.1M	4.3M	2.5M	5.1M	4.6M	7.0M
Other Stockholder Equity	1.6B	1.6B	1.7B	1.9B	2.1B	2.2B
Total Liab	47.4M	23.3M	77.2M	136.3M	156.8M	149.0M
Property Plant And Equipment Gross	295K	6.0M	12.9M	12.0M	10.8M	10.3M
Total Current Assets	157.7M	88.9M	140.9M	176.5M	203.0M	221.8M
Accumulated Other Comprehensive Income	(6K)	(10K)	(428K)	31K	35.7K	37.4K
Short Term Debt	11.0M	12.2M	1.1M	1.3M	1.2M	1.1M
Common Stock	142K	150K	189K	245K	281.8K	295.8K
Other Assets	285K	(45K)	1.2M	136.9M	157.4M	165.3M
Long Term Debt	243.9M	234.2M	48.6M	99.5M	114.4M	77.2M
Property Plant Equipment	14.0M	295K	1.2M	2.1M	1.9M	1.8M
Other Liab	29.9M	55.4M	35.8M	23.3M	26.8M	43.1M
Treasury Stock	(3.8M)	(4.8M)	(7.5M)	(2.1M)	(1.9M)	(1.9M)
Net Tangible Assets	52.8M	111.8M	69.1M	72.6M	65.3M	67.6M
Retained Earnings Total Equity	(1.3B)	(1.4B)	(1.5B)	(1.6B)	(1.4B)	(1.5B)
Capital Surpluse	1.5B	1.6B	1.6B	1.7B	2.0B	1.5B
Inventory	4.7M	4.2M	1.0	381K	438.2K	416.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Lexicon Stock Analysis

When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lexicon Historical Balance Sheet

Lexicon Pharmaceuticals Inventory

416,242

About Lexicon Balance Sheet Analysis

Lexicon Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Lexicon Pharmaceuticals balance sheet Correlations

Lexicon Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lexicon Pharmaceuticals balance sheet Accounts

Also Currently Popular

Additional Tools for Lexicon Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Assets
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Total Liab	+ 0.95	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.89	Short Long Term Debt Total

Cash	- 0.86	Net Debt
Common Stock Shares Outstanding	- 0.8	Retained Earnings
Common Stock	- 0.76	Retained Earnings
Cash And Short Term Investments	- 0.6	Net Debt
Other Assets	- 0.58	Cash
Other Assets	- 0.58	Retained Earnings